查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1831668

液體栓塞劑市場，規模，佔有率，趨勢，產業分析報告:各產品類型，各用途，各終端用戶，各地區，2025年～2034年的市場預測

Liquid Embolic Agent Market Size, Share, & Industry Analysis Report By Product Type (Ethylene Vinyl Alcohol Copolymer (EVOH), Cyanoacrylates, Others), By Application, By End User, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，預計到 2034 年，液體栓塞劑市場規模將達到 6.1305 億美元。本研究報告深入分析了當前的市場動態，並分析了未來的市場成長。

液體栓塞劑是一種用於治療腦動靜脈畸形、動脈瘤和其他血管異常的微創解決方案。這些栓塞劑包括乙烯-乙烯醇 (EVOH) 共聚物、氰基丙烯酸酯黏合劑和其他特殊栓塞材料。

市場成長的驅動因素包括神經血管疾病盛行率的上升、介入性神經放射科醫師數量的增加以及液體栓塞劑相對於傳統治療的臨床優勢。此外，支持性的報銷政策、監管環境以及神經血管介入器材的技術創新正在重塑神經介入治療的格局。

液體栓塞劑市場報告重點

按產品類型劃分，乙烯-乙烯醇 (EVOH) 因其良好的安全性、可控的聚合過程以及在神經血管栓塞中的廣泛應用，在 2024 年佔了市場主導地位。

按應用劃分，動靜脈畸形 (AVM) 領域在 2024 年佔了市場主導地位，這得益於微創栓塞技術的日益普及以及臨床證據的支持。

按最終用戶劃分，醫院在 2024 年佔了最大的市場佔有率，這得益於先進的神經介入設施、熟練的專家資源以及良好的保險覆蓋。

受監管部門批准、先進的醫療保健基礎設施和龐大的神經血管疾病患者群體。

由於中國、印度和日本對栓塞治療的認知度不斷提高、醫療保健投資不斷增加以及先進栓塞技術的採用，預計亞太地區在預測期內的複合年增長率將最快。

全球市場的主要參與者包括美敦力公司、強生公司、史賽克公司、泰爾茂公司、巴爾特集團、波士頓科學公司、Penumbra公司、Merit醫療系統公司、加柏集團、阿森納醫療公司和Meril生命科學私人有限公司。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球液體栓塞劑市場洞察

  • 市場概述
  • 液體栓塞劑市場動態
    • 促進因素和機會
      • 全球神經系統和癌症相關血管疾病發生率上升
      • 政府醫療支出及促進先進療法的政策
    • 限制與挑戰
      • 高昂的手術成本和熟練介入放射科醫師的短缺
  • PESTEL 分析
  • 液態栓塞劑市場趨勢
  • 價值鏈分析

第5章 全球液體栓塞劑市場:各產品類型

  • 主要調查結果
  • 簡介
  • 乙烯-乙烯醇共聚物(EVOH)
  • 氰基丙烯酸酯
  • 其他的產品類型

第6章 全球液體栓塞劑市場:各用途

  • 主要調查結果
  • 簡介
  • 動靜脈畸形(AVM)
  • 多血性腫瘤
  • 末稍血管出血
  • 其他的用途

第7章 全球液體栓塞劑市場:各終端用戶

  • 主要調查結果
  • 簡介
  • 醫院
  • 專門診所
  • 門診病人手術中心(ASC)
  • 其他的終端用戶

第8章 全球液體栓塞劑市場:各地區

  • 主要調查結果
  • 簡介
    • 液體栓塞劑市場評估:地區，2020-2034年
  • 北美
    • 北美:各產品類型，2020～2034年
    • 北美:各用途，2020～2034年
    • 北美:各終端用戶，2020～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各產品類型，2020～2034年
    • 歐洲:各用途，2020～2034年
    • 歐洲:各終端用戶，2020～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各產品類型，2020～2034年
    • 亞太地區:各應用領域，2020～2034年
    • 亞太地區:各終端用戶，2020～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各產品類型，2020～2034年
    • 中東·非洲:各用途，2020～2034年
    • 中東·非洲:各終端用戶，2020～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲
  • 南美
    • 南美:各產品類型，2020-2034年
    • 南美:各用途，2020～2034年
    • 南美:各終端用戶，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第9章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第10章 企業簡介

  • Arsenal Medical Inc.
  • Balt Group
  • Boston Scientific Corporation
  • Chemence Medical Inc.
  • Guerbet Group S.A.
  • Johnson & Johnson
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Merit Medical Systems Inc.
  • Penumbra Inc.
  • Stryker Corporation
  • Terumo Corporation
Product Code: PM6327

The liquid embolic agents market size is expected to reach USD 613.05 million by 2034, according to a new study by Polaris Market Research. The report "Liquid Embolic Agent Market Share, Size, Trends, Industry Analysis Report: By Product Type ((Ethylene Vinyl Alcohol Copolymer (EVOH), Cyanoacrylates, Others), By Application, By End User, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Liquid embolic agents are minimally invasive solutions used for the treatment of cerebral arteriovenous malformations, aneurysms, and other vascular abnormalities. These agents include ethylene vinyl alcohol (EVOH) copolymers, cyanoacrylate adhesives, and other specialized embolic materials.

Market growth is driven by the rising prevalence of neurovascular diseases, an expanding base of interventional neuroradiologists, and clinical advantages of liquid embolic agents over conventional treatments. Moreover, supportive reimbursement policies, regulatory clearances, and technological innovations in neurovascular intervention devices are reshaping the neurointerventional treatment landscape.

Liquid Embolic Agent Market Report Highlights

Based on product type, the ethylene vinyl alcohol (EVOH) segment dominated the market in 2024, driven by its favorable safety profile, controlled polymerization process, and widespread use in neurovascular embolization.

In terms of application, the arteriovenous malformations (AVMs) segment dominated the market in 2024, fueled by rising adoption of minimally invasive embolization procedures and supportive clinical evidence.

Based on end user, the hospitals accounted for the largest market share in 2024, supported by advanced neurointerventional facilities, availability of skilled specialists, and favorable insurance coverage.

North America dominated the liquid embolic agents market in 2024, fueled by strong regulatory approvals, advanced healthcare infrastructure and a large base of neurovascular disease patients.

Asia Pacific is projected to record the fastest CAGR during the forecast period, driven by increasing awareness, growing healthcare investments, and adoption of advanced embolization procedures across China, India, and Japan.

Key players in the global market include Medtronic plc, Johnson & Johnson, Stryker Corporation, Terumo Corporation, Balt Group, Boston Scientific Corporation, Penumbra Inc., Merit Medical Systems Inc., Guerbet Group S.A., Arsenal Medical Inc., Meril Life Sciences Pvt. Ltd., and Chemence Medical Inc.

Polaris Market Research has segmented the market report based on product type, application, end user, and region:

By Product Type Outlook (Revenue, USD Million, 2020-2034)

Ethylene Vinyl Alcohol Copolymer (EVOH)

Cyanoacrylates

N-BCA (n-Butyl Cyanoacrylate)

N-HCA (n-Hexyl Cyanoacrylate)

Other Products

By Application Outlook (Revenue, USD Million, 2020-2034)

Arteriovenous Malformations (AVM)

Hypervascular Tumors

Peripheral Vasculature Hemorrhage

Other Applications

By End User Outlook (Revenue, USD Million, 2020-2034)

Hospitals

Specialty Clinics

Ambulatory Surgical Centers (ASCs)

Other End Users

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Liquid Embolic Agent Market Insights

  • 4.1. Liquid Embolic Agent Market - Market Snapshot
  • 4.2. Liquid Embolic Agent Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Global Rise in Neurological and Cancer-Related Vascular Conditions
      • 4.2.1.2. Government Healthcare Spending and Policies Promoting Advanced Therapies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Procedure Cost and Shortage of Skilled Interventional Radiologists
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Liquid Embolic Agent Market Trends
  • 4.6. Value Chain Analysis

5. Global Liquid Embolic Agent Market, by Product Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • 5.3. Ethylene Vinyl Alcohol Copolymer (EVOH)
    • 5.3.1. Global Liquid Embolic Agent Market, by Ethylene Vinyl Alcohol Copolymer (EVOH), by Region, 2020-2034 (USD Million)
  • 5.4. Cyanoacrylates
    • 5.4.1. Global Liquid Embolic Agent Market, by Cyanoacrylates, by Region, 2020-2034 (USD Million)
  • 5.5. Other Products
    • 5.5.1. Global Liquid Embolic Agent Market, by Other Products, by Region, 2020-2034 (USD Million)

6. Global Liquid Embolic Agent Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • 6.3. Arteriovenous Malformations (AVM)
    • 6.3.1. Global Liquid Embolic Agent Market, by Arteriovenous Malformations (AVM), by Region, 2020-2034 (USD Million)
  • 6.4. Hypervascular Tumors
    • 6.4.1. Global Liquid Embolic Agent Market, by Hypervascular Tumors, by Region, 2020-2034 (USD Million)
  • 6.5. Peripheral Vasculature Hemorrhage
    • 6.5.1. Global Liquid Embolic Agent Market, by Peripheral Vasculature Hemorrhage, by Region, 2020-2034 (USD Million)
  • 6.6. Other Applications
    • 6.6.1. Global Liquid Embolic Agent Market, by Other Applications, by Region, 2020-2034 (USD Million)

7. Global Liquid Embolic Agent Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • 7.3. Hospitals
    • 7.3.1. Global Liquid Embolic Agent Market, by Hospitals, by Region, 2020-2034 (USD Million)
  • 7.4. Specialty Clinics
    • 7.4.1. Global Liquid Embolic Agent Market, by Specialty Clinics, by Region, 2020-2034 (USD Million)
  • 7.5. Ambulatory Surgical Centers (ASCs)
    • 7.5.1. Global Liquid Embolic Agent Market, by Ambulatory Surgical Centers (ASCs), by Region, 2020-2034 (USD Million)
  • 7.6. Other End Users
    • 7.6.1. Global Liquid Embolic Agent Market, by Other End Users, by Region, 2020-2034 (USD Million)

8. Global Liquid Embolic Agent Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Liquid Embolic Agent Market Assessment, By Geography, 2020-2034 (USD Million)
  • 8.3. Liquid Embolic Agent Market - North America
    • 8.3.1. North America: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
    • 8.3.2. North America: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
    • 8.3.3. North America: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.3.4. Liquid Embolic Agent Market - U.S.
      • 8.3.4.1. U.S.: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.3.4.2. U.S.: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.3.4.3. U.S.: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.3.5. Liquid Embolic Agent Market - Canada
      • 8.3.5.1. Canada: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.3.5.2. Canada: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.3.5.3. Canada: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • 8.4. Liquid Embolic Agent Market - Europe
    • 8.4.1. Europe: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
    • 8.4.2. Europe: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
    • 8.4.3. Europe: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.4.4. Liquid Embolic Agent Market - UK
      • 8.4.4.1. UK: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.4.4.2. UK: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.4.4.3. UK: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.4.5. Liquid Embolic Agent Market - France
      • 8.4.5.1. France: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.4.5.2. France: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.4.5.3. France: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.4.6. Liquid Embolic Agent Market - Germany
      • 8.4.6.1. Germany: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.4.6.2. Germany: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.4.6.3. Germany: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.4.7. Liquid Embolic Agent Market - Italy
      • 8.4.7.1. Italy: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.4.7.2. Italy: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.4.7.3. Italy: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.4.8. Liquid Embolic Agent Market - Spain
      • 8.4.8.1. Spain: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.4.8.2. Spain: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.4.8.3. Spain: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.4.9. Liquid Embolic Agent Market - Netherlands
      • 8.4.9.1. Netherlands: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.4.9.2. Netherlands: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.4.9.3. Netherlands: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.4.10. Liquid Embolic Agent Market - Russia
      • 8.4.10.1. Russia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.4.10.2. Russia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.4.10.3. Russia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.4.11. Liquid Embolic Agent Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.4.11.2. Rest of Europe: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.4.11.3. Rest of Europe: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • 8.5. Liquid Embolic Agent Market - Asia Pacific
    • 8.5.1. Asia Pacific: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
    • 8.5.2. Asia Pacific: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
    • 8.5.3. Asia Pacific: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.5.4. Liquid Embolic Agent Market - China
      • 8.5.4.1. China: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.5.4.2. China: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.5.4.3. China: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.5.5. Liquid Embolic Agent Market - India
      • 8.5.5.1. India: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.5.5.2. India: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.5.5.3. India: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.5.6. Liquid Embolic Agent Market - Malaysia
      • 8.5.6.1. Malaysia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.5.6.2. Malaysia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.5.6.3. Malaysia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.5.7. Liquid Embolic Agent Market - Japan
      • 8.5.7.1. Japan: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.5.7.2. Japan: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.5.7.3. Japan: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.5.8. Liquid Embolic Agent Market - Indonesia
      • 8.5.8.1. Indonesia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.5.8.2. Indonesia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.5.8.3. Indonesia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.5.9. Liquid Embolic Agent Market - South Korea
      • 8.5.9.1. South Korea: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.5.9.2. South Korea: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.5.9.3. South Korea: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.5.10. Liquid Embolic Agent Market - Australia
      • 8.5.10.1. Australia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.5.10.2. Australia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.5.10.3. Australia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.5.11. Liquid Embolic Agent Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • 8.6. Liquid Embolic Agent Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
    • 8.6.2. Middle East & Africa: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
    • 8.6.3. Middle East & Africa: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.6.4. Liquid Embolic Agent Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.6.4.2. Saudi Arabia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.6.4.3. Saudi Arabia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.6.5. Liquid Embolic Agent Market - UAE
      • 8.6.5.1. UAE: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.6.5.2. UAE: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.6.5.3. UAE: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.6.6. Liquid Embolic Agent Market - Israel
      • 8.6.6.1. Israel: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.6.6.2. Israel: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.6.6.3. Israel: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.6.7. Liquid Embolic Agent Market - South Africa
      • 8.6.7.1. South Africa: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.6.7.2. South Africa: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.6.7.3. South Africa: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.6.8. Liquid Embolic Agent Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • 8.7. Liquid Embolic Agent Market - Latin America
    • 8.7.1. Latin America: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
    • 8.7.2. Latin America: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
    • 8.7.3. Latin America: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.7.4. Liquid Embolic Agent Market - Mexico
      • 8.7.4.1. Mexico: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.7.4.2. Mexico: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.7.4.3. Mexico: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.7.5. Liquid Embolic Agent Market - Brazil
      • 8.7.5.1. Brazil: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.7.5.2. Brazil: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.7.5.3. Brazil: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.7.6. Liquid Embolic Agent Market - Argentina
      • 8.7.6.1. Argentina: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.7.6.2. Argentina: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.7.6.3. Argentina: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
    • 8.7.7. Liquid Embolic Agent Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
      • 8.7.7.2. Rest of Latin America: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
      • 8.7.7.3. Rest of Latin America: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Arsenal Medical Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Balt Group
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Boston Scientific Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Chemence Medical Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Guerbet Group S.A.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Johnson & Johnson
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Medtronic plc
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Meril Life Sciences Pvt. Ltd.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Merit Medical Systems Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Penumbra Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Stryker Corporation
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Terumo Corporation
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development

List of Tables:

  • Table 1 Global Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 2 Global Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 3 Global Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 4 North America: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 5 North America: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 6 North America: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 7 U.S.: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 8 U.S.: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 9 U.S.: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 10 Canada: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 11 Canada: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 12 Canada: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 13 Europe: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 14 Europe: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 15 Europe: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 16 UK: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 17 UK: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 18 UK: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 19 France: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 20 France: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 21 France: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 22 Germany: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 23 Germany: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 24 Germany: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 25 Italy: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 26 Italy: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 27 Italy: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 28 Spain: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 29 Spain: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 30 Spain: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 31 Netherlands: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 32 Netherlands: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 33 Netherlands: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 34 Russia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 35 Russia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 36 Russia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 37 Rest of Europe: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 38 Rest of Europe: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 39 Rest of Europe: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 40 Asia Pacific: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 41 Asia Pacific: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 42 Asia Pacific: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 43 China: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 44 China: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 45 China: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 46 India: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 47 India: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 48 India: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 49 Malaysia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 50 Malaysia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 51 Malaysia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 52 Japan: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 53 Japan: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 54 Japan: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 55 Indonesia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 56 Indonesia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 57 Indonesia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 58 South Korea: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 59 South Korea: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 60 South Korea: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 61 Australia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 62 Australia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 63 Australia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 64 Rest of Asia Pacific: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 65 Rest of Asia Pacific: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 66 Rest of Asia Pacific: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 67 Middle East & Africa: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 68 Middle East & Africa: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 69 Middle East & Africa: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 70 Saudi Arabia: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 71 Saudi Arabia: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 72 Saudi Arabia: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 73 UAE: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 74 UAE: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 75 UAE: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 76 Israel: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 77 Israel: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 78 Israel: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 79 South Africa: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 80 South Africa: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 81 South Africa: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 82 Rest of Middle East & Africa: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 83 Rest of Middle East & Africa: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 84 Rest of Middle East & Africa: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 85 Latin America: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 86 Latin America: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 87 Latin America: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 88 Mexico: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 89 Mexico: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 90 Mexico: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 91 Brazil: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 92 Brazil: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 93 Brazil: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 94 Argentina: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 95 Argentina: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 96 Argentina: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
  • Table 97 Rest of Latin America: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
  • Table 98 Rest of Latin America: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
  • Table 99 Rest of Latin America: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Liquid Embolic Agent Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product Type
  • Figure 7. Global Liquid Embolic Agent Market, by Product Type, 2024 & 2034 (USD Million)
  • Figure 8. Market by Application
  • Figure 9. Global Liquid Embolic Agent Market, by Application, 2024 & 2034 (USD Million)
  • Figure 10. Market by End User
  • Figure 11. Global Liquid Embolic Agent Market, by End User, 2024 & 2034 (USD Million)